NCT01001832 Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients Status COMPLETED Phase PHASE2/PHASE3
NCT01000610 A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate Status COMPLETED Phase PHASE4
NCT01000441 Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00996606 A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs Status COMPLETED Phase PHASE3
NCT00996203 A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs. Status COMPLETED Phase PHASE4
NCT00995449 Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT00993668 Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines Status COMPLETED Phase PHASE4
NCT00993317 A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00989235 Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00984815 Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Status COMPLETED Phase PHASE3
NCT00984711 Observational Study of Rituxan in Rheumatoid Arthritis Patients in Routine Clinical Practice Status UNKNOWN Phase N/A
NCT00977106 TORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNF Status COMPLETED Phase PHASE3
NCT00976599 A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00969527 Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00968266 Improving Beliefs About Medication in Patients With Rheumatoid Arthritis Status COMPLETED Phase NA